IEXIndustrials · Specialty Industrial MachineryThe 15 Wall Street analysts covering IDEX Corp. hold a median 12-month price target of $259 — +8.2% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 92 of 100 as at 28 Oct 2026 — among the strongest tenth. Here, the model and the Street point the same way.
Consensus tells you what everyone already believes. The model scores IDEX Corp. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Revisions (98): Analysts have, on balance, been raising their forecasts.
Value (49): The shares cost a lot relative to the profits and assets behind them.
Size (11): Larger than most of the companies we track — more scrutinised, less often mispriced.
Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.
The bullish and bearish analyst opinions on IEX, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
The green dot is the last close — the median target sits +8.2% from it.
Of the 20 most recent actions, 11 moved their price target up and 0 moved it down.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 21 Oct 2026 | Oppenheimer | Maintains | Outperform | $270 → $275 |
| 14 Oct 2026 | RBC Capital | Maintains | Outperform | $280 → $285 |
| 9 Sept 2026 | Oppenheimer | Maintains | Outperform | $265 → $270 |
| 9 Sept 2026 | Oppenheimer | Maintains | Outperform | — |
| 12 Aug 2026 | Mizuho | Upgrade | Outperform | $210 → $280 |
| 12 Aug 2026 | Mizuho | Upgrade | Outperform | — |
| 6 Aug 2026 | Argus Research | Maintains | Buy | $250 → $260 |
| 6 Aug 2026 | Argus Research | Maintains | Buy | — |
| 6 Aug 2026 | DA Davidson | Maintains | Neutral | — |
| 6 Aug 2026 | DA Davidson | Maintains | Neutral | $230 → $240 |
| 30 July 2026 | Citigroup | Maintains | Buy | $252 → $269 |
| 30 July 2026 | Citigroup | Maintains | Buy | — |
| 30 July 2026 | RBC Capital | Maintains | Outperform | — |
| 30 July 2026 | RBC Capital | Maintains | Outperform | $261 → $280 |
| 30 July 2026 | Stifel | Maintains | Buy | $257 → $268 |
| 30 July 2026 | Stifel | Maintains | Buy | — |
| 30 July 2026 | TD Cowen | Maintains | Buy | $260 → $275 |
| 30 July 2026 | TD Cowen | Maintains | Buy | — |
| 21 July 2026 | Oppenheimer | Maintains | Outperform | $250 → $260 |
| 21 July 2026 | Oppenheimer | Maintains | Outperform | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
IEX appears in the Radar on the weeks it earns a place.
AI cloud capacity
MSFTAMZNGOOGLORCL
AI chips
NVDAAVGOAMDMU
AI networking and serversIn full
ANETDELLLITECRDO
Data centre power
VRTCEGGEVVST
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 29 Oct 2026, IDEX Corp. returned +39.9% against +13.6% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 23% of US stocks
Cheaper than 24% of US stocks
Cheaper than 22% of US stocks
Cheaper than 16% of US stocks
Higher than 44% of US stocks
Higher than 47% of US stocks
Higher than 57% of US stocks
Higher than 81% of US stocks
Higher than 77% of US stocks
Higher than 70% of US stocks
Higher than 84% of US stocks
Higher than 73% of US dividend payers
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
IDEX Corp. has a market value of $17.2B and an enterprise value of $18.5B.
Revenue in the twelve months to 30 June 2026: $3.6B. The latest quarter grew 6.4% year on year.
Net income over the same four quarters: $519.3M, a 14.5% net margin.
Diluted earnings per share, trailing twelve months: $6.95.
Free cash flow in the twelve months to 30 June 2026: $641.5M, after $75.2M of capital spending.
IDEX Corp. spent $301.5M on share buybacks and $213.4M on dividends in the twelve months to 30 June 2026.
Trailing P/E: 33.6×; forward P/E: 24.2× — the forward figure prices analyst consensus estimates, not reported earnings.
Forward dividend yield: 1.24%, paying out 52% of earnings.
IDEX Corp. employs 8,700 people — $412K of revenue per employee.
Data provided by Twelve Data
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own IDEX Corp. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
The item is the transcript of IDEX Corporation’s Q3 2026 earnings call; no further details are provided in the excerpt.
Why it matters — IEX watchers may use the earnings-call transcript to review the company’s quarterly discussion, but the excerpt contains no information about its contents.
Zacks says Idex’s Q3 headline results for the quarter ended September 2026 provide a view of its performance. The article focuses on comparing key metrics with Wall Street estimates and year-ago actuals.
Why it matters — These comparisons offer IEX watchers context for evaluating the quarter’s results against expectations and the prior year.
Idex reported quarterly earnings of $2.33 per share, above the Zacks Consensus Estimate of $2.23. Earnings were $2.03 per share in the same period a year earlier.
Why it matters — The results show quarterly earnings exceeded estimates and were higher than a year ago, key performance details for IEX watchers.
IDEX reported record sales and adjusted EPS for the third quarter ended September 30, 2026, with expanding margins and nearly $1 billion in orders. The company attributed performance to advantaged markets and larger acquired businesses, noting momentum across the rest of its business.
Why it matters — IEX watchers may note the reported records, margin expansion, and order volume as indicators of the quarter's business performance.
IDEX heads into its Q3 2026 earnings report with expected revenue growth from Health & Science Technologies and acquisitions, while rising costs may pressure profits.
Why it matters — IEX watchers may want to follow how revenue growth drivers and rising costs shape the company's earnings report.
The 15 Wall Street analysts covering IDEX Corp. have a median 12-month price target of $259, with estimates ranging from $215 to $285. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Of the 15 analysts covering IDEX Corp., 10 rate it a Buy, 5 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks IDEX Corp. 92 out of 100 across roughly 4,600 US stocks as at 28 Oct 2026. None of this is personal advice — it does not consider your circumstances.
As at 28 Oct 2026, IDEX Corp. ranks 92 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Revisions (98 of 100).
No one can know that. What the data says: the median 12-month target from 15 analysts implies +8.2% from the last close, and Ticker Nerd's factor model ranks IDEX Corp. 92 out of 100 as at 28 Oct 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
No analyst covering IDEX Corp. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for IEX are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $215 to $285 over the next 12 months.
IDEX Corp. returned +39.9% over the 12 months to 29 Oct 2026, with dividends reinvested. Past performance does not indicate future returns.
IDEX Corporation is a global engineered products company that develops mission-critical solutions for specialized industrial markets. The company designs and manufactures highly engineered components and applied systems used to move, measure, control, and dispense fluids and other materials with precision.
The most recent item we track (Seeking Alpha, 28 Oct 2026): "IDEX Corporation (IEX) Q3 2026 Earnings Call Transcript". The item is the transcript of IDEX Corporation’s Q3 2026 earnings call; no further details are provided in the excerpt.
IDEX Corporation is a global engineered products company that develops mission-critical solutions for specialized industrial markets. The company designs and manufactures highly engineered components and applied systems used to move, measure, control, and dispense fluids and other materials with precision. Its operations are organized across three main business segments: Fluid & Metering Technologies, Health & Science Technologies, and Fire & Safety/Diversified Products. These businesses serve a broad range of end markets, including water and wastewater, food and pharmaceutical processing, life sciences, analytical instruments, semiconductor, energy, transportation, and emergency response. IDEX’s product portfolio includes pumps, valves, flow meters, fluidics systems, rescue tools, and other application-specific equipment built for demanding environments. Headquartered in Northbrook, Illinois, IDEX focuses on niche markets where reliability, customization, and performance are essential.
CEO Mr. Eric D. Ashleman · 8,700 employees · United States · https://www.idexcorp.com
